Lyell Immunopharma Appoints Matthew Lang as Chief Business Officer
Go back to Lyell Immunopharma Appoints Matthew Lang as Chief Business Officer| (NASDAQ: LYEL) | Delayed: 15.53 +0.18 (1.17%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $15.35 | 52 Week High | $ | |||
| Open | $15.54 | 52 Week Low | $ | |||
| Day High | $16.16 | P/E | N/A | |||
| Day Low | $15.20 | EPS | $ | |||
| Volume | 104,915 | |||||
